Results 21 to 30 of about 299,030 (338)

Increased telomere attrition following renal transplantation: impact of anti-metabolite therapy [PDF]

, 2016
Background: The uremic milieu exposes chronic kidney disease (CKD) patients to premature ageing processes. The impact of renal replacement therapy (dialysis and renal transplantation [RTx]) or immunosuppressive treatment regimens on ageing biomarkers has
Bárány, Peter, Curley, Hannah, Genberg, Helena, Luttropp, Karin, McGuinness, Dagmara, Nordfors, Louise, Quasim, Tara, Qureshi, Abdul Rashid, Sandberg, John, Schalling, Martin, Shiels, Paul G., Stenvinkel, Peter, Sönnerborg, Isabella, Wennberg, Lars   +13 more
core   +1 more source

Improving dialysis adherence for high risk patients using automated messaging: Proof of concept [PDF]

, 2017
Comorbidities and socioeconomic barriers often limit patient adherence and self-management with hemodialysis. Missed sessions, often associated with communication barriers, can result in emergency dialysis and avoidable hospitalizations.
An, T., Groenendyk, J., Patel, K., Peters, R., Polites, G., Ross, W. R, Som, A.   +6 more
core   +2 more sources

Peritoneal dialysis in older adults: evaluation of clinical, nutritional, metabolic outcomes, and quality of life [PDF]

, 2018
The number of older adults requiring dialysis is increasing worldwide, whereas the use of peritoneal dialysis (PD) in this population is lower respect to younger patients, despite the theoretical advantages of PD respect to hemodialysis.
Aceto, Paola, Amabile, MARIA IDA, Bargagli, Matteo, Gnerre Musto, Tania, Group on Geriatric Nephrology of the Italian Society of Nephrology (SIN), Study, Lai, Carlo, Lai, Silvia, Martinez, Andrea, Mastroluca, Daniela, Molfino, Alessio, Testorio, Massimo   +10 more
core   +1 more source

Acute kidney injury in non-critical care setting: elaboration and validation of an in-hospital death prognosis score

BMC Nephrology, 2019
Background Acute kidney injury (AKI) is still characterized by a high mortality rate. While most patients with AKI are admitted in conventional medical units, current available data are still obtained from studies designed for patients admitted in ...
Jamal Bamoulid, Hélène Philippot, Amir Kazory, Maria Yannaraki, Thomas Crepin, Bérengère Vivet, Nadège Devillard, Caroline Roubiou, Catherine Bresson-Vautrin, Jean-Marc Chalopin, Cécile Courivaud, Didier Ducloux   +11 more
doaj   +1 more source

Disease severity adversely affects delivery of dialysis in acute renal failure [PDF]

, 2007
Background/Aims: Methods of intermittent hemodialysis (IHD) dose quantification in acute renal failure (ARF) are not well defined. This observational study was designed to evaluate the impact of disease activity on delivered single pool Kt/V-urea in ARF ...
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference, Clark WR, Daugirdas JT, Daugirdas JT, Evanson JA, Evanson JA, Helmut Schiffl, Himmelfarb J, Ikizler TA, Jaber BL, Kanagasundaram NS, Klouche K, Knaus WA, Leblanc M, Liangos O, Marshall MR, Paganini EP, Paganini EP, Saudan P, Watson PE, Weisbord SD   +20 more
core   +1 more source

Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study

BMJ Open Diabetes Research & Care, 2020
Introduction Differences in mortality and cause-specific mortality rates according to glycated albumin (GA) and hemoglobin A1c (HbA1c) levels among dialysis patients with diabetes based on hypoglycemic agent use and malnutrition status remain unclear ...
Takayuki Hamano, Masanori Abe, Atsushi Wada, Kenmei Takaichi, Shigeru Nakai, Ikuto Masakane, Kosaku Nitta   +6 more
doaj   +1 more source

Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report

Journal of Medical Case Reports, 2023
Background Apixaban is a non-vitamin K antagonist oral anticoagulant (NOACs) recently emerged as an effective alternative to conventional vitamin K antagonists (VKAs) in the treatment of several thromboembolic disorders.
Vittorio Dalmastri, Andrea Angelini, Vera Minerva, Melissa Ballarini, Francesco Grammatico, Paola Todeschini, Attilia Maria Pizzini, Mauro Silingardi, Gaetano La Manna   +8 more
doaj   +1 more source

Determinants of urgent start dialysis in a chronic kidney disease cohort followed by nephrologists

BMC Nephrology, 2023
Background The French Renal Epidemiology and Information Network (REIN) registry collect dialysis initiation context for each patient starting dialysis with a flawed definition of urgent start dialysis (USD).
Amin Tachikart, Clément Vachey, Charline Vauchy, Caroline Savet, Didier Ducloux, Cécile Courivaud   +5 more
doaj   +1 more source

Randomized control trial of prednisolone and doxycycline in patients with acute interstitial nephritis of unknown aetiology

Trials, 2023
Background Patients presenting with acute interstitial nephritis (AIN) of unknown aetiology, probably the earliest presentation of chronic kidney disease of unknown aetiology (CKDu), have been treated with oral prednisolone and doxycycline by physicians ...
Zeid Badurdeen, Neelakanthi Ratnatunga, Tilak Abeysekera, Abdul. W. M. Wazil, Premil N. Rajakrishna, Jalitha P. Thinnarachchi, Dulani D. Welagedera, Nadeeka Ratnayake, Adambarage. P. D. Alwis, Hemalika Abeysundara, Ranjith Kumarasiri, Richard Taylor, Nishantha Nanayakkara   +12 more
doaj   +1 more source

Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism

Kidney and Dialysis, 2022
Background. Secondary hyperparathyroidism (SHPT) is a major risk factor for cardiovascular events and all-cause mortality in hemodialysis (HD) patients. The purpose of our study was to evaluate the effects and tolerability of etelcalcetide in HD patients
Paola Monciino, Lorenza Magagnoli, Eliana Fasulo, Michela Frittoli, Chiara Leotta, Hoang Nhat Pham, Andrea Stucchi, Paola Ciceri, Andrea Galassi, Mario Cozzolino   +9 more
doaj   +1 more source